G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease

Investigators observed the induction of neuronal plasticity and a reduction of neuroinflammation after G9a inhibitor treatment, and these neuroprotective effects were reverted by the pharmacological inhibition of GMFB in mice and cell cultures.